Sotto A, De Boever C M, Fabbro-Peray P, Gouby A, Sirot D, Jourdan J
Laboratoire Universitaire de Thérapeutique, Service de Médecine Interne B, Hôpital Carémeau, Nîmes, France.
J Clin Microbiol. 2001 Feb;39(2):438-44. doi: 10.1128/JCM.39.2.438-444.2001.
From November 1998 to February 1999 we prospectively evaluated the prevalence of resistance to penicillins, cephalosporins, carbapenem, quinolones, aminoglycosides, and trimethoprim-sulfamethoxazole (SXT) in 320 Escherichia coli isolates isolated from hospitalized patients with acute urinary tract infections (UTIs). We also studied for these strains risk factors for resistance to amoxicillin-clavulanic acid (AMC), fluoroquinolones (FQs), and SXT. Resistance rates were consistent with those from major recent studies reported in the literature. Multivariate analyses selected the following factors as being significantly associated with E. coli resistance: (i) for resistance to AMC, prior (1 year) UTI (odds ratio [OR] = 2.71, P = 0.006), prior (1 year) urinary catheter (OR = 2.98, P = 0.0025), and prior (6 months) antibiotic exposure (OR = 2.68, P = 0.005); (ii) for resistance to FQs male sex (OR = 3.87, P = 0.03), with a trend toward significance for age >65 years (OR = 7.67, P = 0.06) and prior (1 year) UTI (OR = 2.98, P = 0.07); and (iii) for resistance to SXT, male sex (OR = 1.91, P = 0.046), hospitalization in an intermediate-term-care unit (OR = 2.18, P = 0.008), and prior (1 year) UTI (OR = 2.03, P = 0.03). Ours results suggest that prior UTI is a common risk factor for resistance to the different antibiotics tested. Although few studies on risk factors for E. coli resistance to antibiotics have been published, careful interpretation of their findings, taking into consideration the population, infection site, and period studied, should contribute to the formulation of a better strategy that can be used to overcome antibiotic resistance.
1998年11月至1999年2月,我们前瞻性评估了从急性尿路感染(UTI)住院患者中分离出的320株大肠杆菌对青霉素、头孢菌素、碳青霉烯类、喹诺酮类、氨基糖苷类以及甲氧苄啶-磺胺甲恶唑(SXT)的耐药率。我们还研究了这些菌株对阿莫西林-克拉维酸(AMC)、氟喹诺酮类(FQs)和SXT耐药的危险因素。耐药率与近期文献报道的主要研究结果一致。多变量分析选择了以下因素作为与大肠杆菌耐药显著相关的因素:(i)对于AMC耐药,既往(1年)UTI(比值比[OR]=2.71,P=0.006)、既往(1年)导尿(OR=2.98,P=0.0025)以及既往(6个月)抗生素暴露(OR=2.68,P=0.005);(ii)对于FQs耐药,男性(OR=3.87,P=0.03),年龄>65岁有显著趋势(OR=7.67,P=0.06)以及既往(1年)UTI(OR=2.98,P=0.07);(iii)对于SXT耐药,男性(OR=1.91,P=0.046)、在中期护理病房住院(OR=2.18,P=0.008)以及既往(1年)UTI(OR=2.03,P=0.03)。我们的结果表明,既往UTI是对所测试的不同抗生素耐药的常见危险因素。虽然关于大肠杆菌抗生素耐药危险因素的研究很少发表,但在考虑所研究的人群、感染部位和时间段的情况下,仔细解读其研究结果应有助于制定更好的策略以克服抗生素耐药性。